Detection of Anti-LKM-1(Anti-CYP2D6) by an: Enzyme-Linked Immunosorbent Assay in Adult Patients with Chronic Liver Diseases

References

• Smith M. G.M., Williams R., Walker G., Rizzetto M., Doniach D. Hepatic disorders associated with liver/kidney microsomal antibodies. Br. Med. J. 1974; 2: 80–84
   PubMed Web of Science ®Google Scholar
• Homberg J. C., Abuaf N., Bernard O., Islam S., Alvarez F., Khalil S. H., Poupon R., Darnis F., Lëvy V. G., Grippon P., Opolon P., Bernuau J., Alagille D. Chronic active hepatitis associated with anti-liver/ kidney microsome antibody type 1: a second type of “autoimmune hepatitis”. Hepaiology 1987; 7: 1333–1339
   PubMed Web of Science ®Google Scholar
• Lenzi M., Ballardini G., Fusconi M., Cassani F., Selleri L., Volta U., Zauli D., Bianchi F. B. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 258–259
   PubMed Web of Science ®Google Scholar
• Vento S., DiPerri G., Luzzati R., Garofano T., Concia E., Bassetti D. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 921–922
   PubMedGoogle Scholar
• Miyakawa H., Kako M., Nagai K., Hino K., Iwabuchi S., Miyachi K., Okamoto H., Mayumi M. HCV-RNA in type 2 autoimmune hepatitis. Am. J. Gastroenterol. 1991; 86: 1688–1689
   PubMed Web of Science ®Google Scholar
• Manns M. P., Nakamura R. M. Autoimmune liver diseases. Clinics in Lab. Med. 1988; 8: 281–301
   PubMed Web of Science ®Google Scholar
• Manns M., Meyerzum Büschenfelde K.-H., Slusarczyk J., Dienes H. P. Detection of liver-kidney micro-somal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases. Clin. Exp. Immunol. 1984; 57: 600–608
   PubMed Web of Science ®Google Scholar
• Manns M. P., Johnson E. F., Griffin K. J., Tan E. M., Sullivan K. F. Major antigen of liver kidney microsome autoantibodies in ideopathic autoimmune hepatitis is cytochrome P450 dbl. J. Clin. Invest. 1989; 83: 1066–1072
   PubMed Web of Science ®Google Scholar
• Gueguen M., Boniface O., Bernard O., Clerc F., Cartwright T., Alvarez F. Identification of the main epitope on human cytochrome P450IID6 recognized by anti-liver kidney microsome antibody. J. Autoimmun. 1991; 4: 607–615
   PubMed Web of Science ®Google Scholar
• Yamamoto A. M., Cresteil D., Boniface O., Clere F. F., Alvarez F. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKMI). Eur. J. Immunol. 1993; 23: 1105–1111
   PubMed Web of Science ®Google Scholar
• Ma Y., Peakman M., Lobo-Yeo A., Wen L., Lenzi M., Gäken J., Farzaneh F., Mieli-Vergani G., Bianchi F. B., Vergani D. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal(LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin. Exp. Immunol. 1994; 97: 94–99
   PubMed Web of Science ®Google Scholar
• Zanger U. M., Hauri H.-P., Loeper J., Homberg J. C., Mayer U. A. Antibodies against human cytochrome P-450dbl in autoimmune hepatitis type II. Proc. Nail. Acad. Sci. USA 1988; 85: 8256–8260
   PubMed Web of Science ®Google Scholar
• Yamamoto A. M., Johanet C., Duclos-Vallee J.-C., Bustarret A., Alvarez F. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2(AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay. Clin. Exp. Immunol. 1997; 108: 396–400
   PubMed Web of Science ®Google Scholar
• Ma Y., Gregorio G., Gäken J., Muratori L., Bianchi F. B., Mieli-Vergani G., Vergani D. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection. J. Hepatol. 1997; 26: 1396–1402
   PubMed Web of Science ®Google Scholar
• Johnson P. J., McFarlane I. G. Meeting report: international autoimmune hepatitis group. Hepatology 1993; 18: 998–1005
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J., Skoda R. C., Kimura S., Umeno M., Zanger U. M., Nebert D. W., Gelboin H. V., Hardwick J. P., Meyer U. A. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988; 331: 442–446
   PubMed Web of Science ®Google Scholar
• Frangioni J. V., Neel B. G. Solubilization and purification of enzymatically active glutathione S transferase (pGEX) fusion proteins. Anal. Biochem. 1993; 210: 179–187
   PubMed Web of Science ®Google Scholar
• Rizzetto M., Bianchi F. B., Doniach D. Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology 1973; 26: 589–601
   Web of Science ®Google Scholar
• Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets. Proc. Nail. Acad. Sci. USA 1979; 76: 4350–4354
   PubMed Web of Science ®Google Scholar
• Gregorio G. V., Portmann B., Reid F., Donaldson P. T., Doherty D. G., MaCartney M., Mowat A. P., Vergani D., Mieli-Vergani G. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997; 25: 541–547
   PubMed Web of Science ®Google Scholar
• Porta G., Gayotto L. C.C., Alvarez F. Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure. 1. Ped. Gastroenterol. Nutr. 1990; 11: 138–140
   PubMed Web of Science ®Google Scholar
• Michel G., Ritter A., Gerken G., Meyer zum-Büchenferde K.-H., Decker R., Manns M. P. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 1992; 339: 267–269
   PubMed Web of Science ®Google Scholar
• Strassberg C. P., Manns M. P. Autoimmune hepatitis versus viral hepatitis C. Liver 1995; 15: 225–232
   PubMedGoogle Scholar
• Miyakawa H., Kitazawa E., Abe K., Kawaguchi N., Fuzikawa H., Kikuchi K., Kako M., Komatsu T., Hayashi N., Kiyosawa K. Chronic hepatitis C associated with anti-liver/kidney microsome-I antibody is not a subgroup of autoimmune hepatitis. J. Gastroenterol. 1997; 32: 769–776
   PubMed Web of Science ®Google Scholar
• Nishioka M., Morshed S. A., Kono K., Hitomi T., Parveen S., Arima K., Wakanabe S., Manns M. P. Frequency and significance of antibodies to P4501ID6 protein in Japanese patients with chronic hepatitis C. J. Hepatol. 1997; 26: 992–1000
   PubMed Web of Science ®Google Scholar
• Todros L., Saracco G., Durazzo M., Abata M. L., Touscoz G., Scaglione L., Verme G., Rizzetto M. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology 1995; 22: 1374–1378
   PubMed Web of Science ®Google Scholar
• Calleja J. L., Albillos A., Cacho G., Iborra J., Abreu L., Escartin P. Interferon and prednisolone therapy in chronic hepatitis C with non-organ-specific antibodies. J. Hepatol. 1996; 24: 308–312
   PubMed Web of Science ®Google Scholar
• Homberg J. C., Andre C., Abuaf N. A new anti-liver-kidney microsome antibody (anti-LKM-2) in tienilic acid-induced hepatitis. Clin. Exp. Immunol. 1984; 55: 561–570
   PubMed Web of Science ®Google Scholar
• Crivelli O., Lavarini C., Chiaberge E., Amoroso A., Farci P., Negro F., Rizzetto M. Microsomal autoantibodies in chronic infection with the HBs-Ag associated delta agent. Clin. Exp. Immunol. 1983; 54: 232–238
   PubMed Web of Science ®Google Scholar
• Bourdi M., Larrey D., Nataf J., Bernuau J., Pessayre D., Iwasaki M., Guengerich F. P., Beaune P. H. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450Ia2. A specific marker of dihydrazine-induced hepatitis. J. Clin. Invesr. 1990; 85: 1967–1973
   PubMed Web of Science ®Google Scholar
• Martini E., Abuaf N., Cavalli F., Durard V., Johanet C., Homberg J.-C. Antibody to liver cytosol (anti-LCI) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988; 8: 1662–1666
   PubMed Web of Science ®Google Scholar
• Manns M. P. Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance. Sem. Liver Dis. 1991; 11: 205–214
   PubMed Web of Science ®Google Scholar
• Manns M. P., Griffin K. J., Sullivan K., Johnson E. F. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J. Clin. Invest. 1991; 88: 1370–1378
   PubMed Web of Science ®Google Scholar